Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Adherium Ltd. ( (AU:ADR) ).
Adherium Limited has disclosed that K One W One Limited has ceased to be a substantial shareholder in the company. The change arose from a dilution of K One W One’s voting power following new share issues by Adherium, affecting 146,836,248 ordinary shares.
The cessation of K One W One’s substantial holding status may signal a shift in Adherium’s shareholder base and capital structure. This development could alter the company’s governance dynamics and potentially influence investor perceptions of control and future funding flexibility.
The most recent analyst rating on (AU:ADR) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Adherium Ltd. stock, see the AU:ADR Stock Forecast page.
More about Adherium Ltd.
Adherium Limited is a healthcare technology company focused on respiratory disease management. It develops and supplies digital inhaler monitoring devices and related software that help patients and clinicians track medication use and improve adherence, targeting markets where chronic respiratory conditions such as asthma and COPD are prevalent.
Technical Sentiment Signal: Sell
Current Market Cap: A$12.36M
See more insights into ADR stock on TipRanks’ Stock Analysis page.